Chang Liu - 25 Aug 2025 Form 3 Insider Report for Curanex Pharmaceuticals Inc

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
02 Sep 2025, 20:30:11 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Chang Liu
Filing notes and source

Key filing fact

Chang Liu filed Form 3 for Curanex Pharmaceuticals Inc on 02 Sep 2025.

Key facts

  • This page summarizes Chang Liu's Form 3 filing for Curanex Pharmaceuticals Inc.
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Sep 2025, 20:30.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002084036 Primary reporting owner

Liu Chang

Relationship
10%+ Owner
Address
C/O CURANEX PHARMACEUTICALS INC, 2 JERICHO PLAZA SUITE 101 B, JERICHO
Signature
/s/ Chang Liu
Signature date
02 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CURX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,870,020
Date
25 Aug 2025
Ownership
Direct
CURX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,340,000
Date
25 Aug 2025
Ownership
See footnote
Footnotes
F1
CURX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
772,200
Date
25 Aug 2025
Ownership
See footnote
Footnotes
F2
CURX holding

Series A Preferred Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
310,000
Date
25 Aug 2025
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares of common stock are held directly by Korovyev Hippo LLC, an entity in which the Reporting Person has the sole voting and investment power. By virtue of this relationship, the Reporting Person may be deemed to have the sole beneficial ownership of the securities held of record by Korovyev Hippo LLC.

Footnote F2

These shares of common stock are held directly by Liu and Company LLC, an entity in which the Reporting Person has the sole voting and investment power. By virtue of this relationship, the Reporting Person may be deemed to have the sole beneficial ownership of the securities held of record by Liu and Company LLC.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .